Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 19, Travere Therapeutics Inc. (NASDAQ:TVTX) released the fourth ...
Vertex Pharmaceuticals VRTX announced positive data from an interim analysis of the ongoing phase III RAINER study, which evaluated its investigational drug povetacicept for IgA nephropathy (IgAN) ...
Vertex Pharmaceuticals has a rolling biologics license application with the FDA for povetaciceptin IgA nephropathy. With new data from RAINIER, the biotech expects to complete its submission by the ...
Investor's Business Daily on MSN
IBD stock of the day: Ligand Pharma, biotech's royalty arm, breaks out
Ligand Pharmaceuticals is Tuesday's IBD Stock Of The Day. The biotech stock has blown past several buy points on its way to a new breakout.
Investor's Business Daily on MSN
How a broad sell-off rattled top 3% breakout stock Ligand Pharma
Shares of Ligand Pharmaceuticals dropped into a sell zone Thursday, seemingly down in sympathy with the broader biotech segment.
Detailed price information for Enanta Pharmaceutica (ENTA-Q) from The Globe and Mail including charting and trades.
Janus Henderson Global Life Sciences Fund returned 18.66% and the MSCI World Health Care Index SM returned 10.60%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results